Ipamorelin UAE | Buy Research-Grade Ipamorelin Peptide | ≥99% Purity

Ipamorelin is a selective pentapeptide growth hormone secretagogue studied in endocrinology and metabolic research for its ability to stimulate growth hormone release through ghrelin receptor activation — with a notably clean selectivity profile that makes it one of the most precise GH-releasing peptides available as a research tool. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade Ipamorelin with fast international dispatch and full batch documentation included.

✅ ≥99% Purity — HPLC & Mass Spectrometry Verified

✅ Batch-Specific Certificate of Analysis (CoA) Included

✅ Sterile Lyophilised Powder | GMP Manufactured

✅ Fast International Dispatch to UAE & GCC

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide (five amino acids) developed as a selective growth hormone secretagogue — a compound that stimulates the release of growth hormone from the pituitary gland. It acts as an agonist at the ghrelin receptor (GHSR-1a), the same receptor targeted by the hunger hormone ghrelin, but with a more selective pharmacological profile than many earlier growth hormone secretagogues.

What distinguishes Ipamorelin in research is its selectivity: unlike some other GH-releasing peptides and secretagogues, Ipamorelin stimulates GH release without significantly affecting cortisol, prolactin, or ACTH levels in pre-clinical models — making it a cleaner research tool for studying growth hormone axis dynamics in isolation. This selectivity has made it a consistently popular compound for endocrinology laboratories, and research interest from institutions across the UAE and GCC continues to grow alongside expanding interest in growth hormone axis and metabolic research in the region.

What Does Ipamorelin Do in Research?

In controlled laboratory and pre-clinical research settings, Ipamorelin has been studied across several focused endocrinology and metabolic research applications:

Growth Hormone Secretion Studies: Ipamorelin’s primary research application is as a selective GHSR-1a agonist that stimulates pulsatile growth hormone release from the anterior pituitary. Studies use it to examine how GH secretion dynamics are regulated, what downstream effects GH release produces, and how the GH/IGF-1 axis responds to secretagogue stimulation.

Ghrelin Receptor Pharmacology: Research has used Ipamorelin to characterise ghrelin receptor binding kinetics, receptor activation mechanisms, and downstream signalling cascades — providing insights into GHSR-1a pharmacology independently of ghrelin’s broader metabolic effects.

Hypothalamic-Pituitary Axis Research: Studies have incorporated Ipamorelin into models examining the regulation of the growth hormone axis, exploring how GH secretagogue stimulation interacts with natural GHRH and somatostatin regulation of pituitary GH output.

Body Composition Research: Pre-clinical studies have examined how sustained GH secretagogue stimulation via Ipamorelin affects body composition parameters including lean mass, fat mass distribution, and metabolic rate markers in animal models.

Bone Density Research: Research has explored Ipamorelin’s influence on bone formation markers and skeletal tissue parameters in pre-clinical models, reflecting growth hormone’s known role in bone metabolism and density regulation.

Metabolic Research: Studies have examined how Ipamorelin-stimulated GH release influences downstream metabolic parameters including IGF-1 levels, insulin sensitivity, and lipid metabolism in pre-clinical experimental settings.

Selectivity Studies: A significant body of research has specifically examined Ipamorelin’s selectivity profile — documenting its lack of significant cortisol, prolactin, and ACTH stimulation compared to earlier secretagogues — establishing it as a reference compound for selective GH axis research.

Gastrointestinal Research: As a ghrelin receptor agonist, Ipamorelin has also been studied in gastrointestinal motility models, reflecting the ghrelin receptor’s presence throughout the GI tract and its role in gut motility regulation.

All applications listed are research-based only. Ipamorelin is not approved for human therapeutic use.

What Do Studies Say About Ipamorelin?

Ipamorelin has developed a well-regarded pre-clinical research profile centred on its selective GH-releasing properties:

Pharmacological studies established Ipamorelin’s selectivity profile early in its research history, with comparative studies documenting significantly lower cortisol and ACTH stimulation compared to earlier GH secretagogues like GHRP-2 and GHRP-6 — confirming its value as a cleaner research tool for isolating GH axis effects without hypothalamic-pituitary-adrenal axis interference. Pre-clinical body composition studies have reported increases in lean mass and reductions in fat mass parameters in animal models following sustained Ipamorelin administration, with research examining how pulsatile GH stimulation influences tissue composition over time. Bone research has documented Ipamorelin’s influence on bone formation markers in pre-clinical models, with studies examining cortical and trabecular bone parameters in growing and aged animal models under GH secretagogue stimulation. Gastrointestinal research has examined Ipamorelin in gut motility models, with studies exploring its effects on gastric emptying and intestinal transit — reflecting the ghrelin receptor’s significant presence in GI tissue. Comparative secretagogue research has consistently positioned Ipamorelin as a reference compound for selective GH stimulation, with its clean hormonal selectivity profile making it a preferred tool for studies requiring GH axis stimulation without broader endocrine system disruption.

Ipamorelin vs Other GH Secretagogue Research Peptides

Feature	Ipamorelin	GHRP-2	GHRP-6	CJC-1295
Type	Pentapeptide secretagogue	Hexapeptide secretagogue	Hexapeptide secretagogue	GHRH analogue
Receptor	GHSR-1a	GHSR-1a	GHSR-1a	GHRHR
GH Release	Selective, pulsatile	Strong	Strong	Sustained
Cortisol Stimulation	Minimal	Moderate	Moderate	Minimal
Prolactin Stimulation	Minimal	Moderate	Low	Minimal
Appetite Effects	Minimal	Minimal	Notable	Minimal
Selectivity Profile	Excellent	Moderate	Moderate	Good

Product Specifications

Parameter	Specification
Type	Pentapeptide Growth Hormone Secretagogue
Receptor Target	GHSR-1a (Ghrelin Receptor)
Purity	≥99% (HPLC & MS Verified)
Form	Sterile Lyophilised Powder
Solubility	Sterile water, bacteriostatic water
Storage (powder)	-20°C, protect from light
Storage (reconstituted)	2–8°C, use within 2–4 weeks

Buying Ipamorelin in UAE — What’s Included

Every order of Ipamorelin dispatched to the UAE and GCC includes:

• Batch-specific Certificate of Analysis (CoA)
• HPLC Chromatogram
• Mass Spectrometry Confirmation
• Sterility & Endotoxin Testing Report
• Reconstitution Protocol
• Technical Research Support

Frequently Asked Questions — Ipamorelin UAE

Can I buy Ipamorelin peptide in the UAE?

Yes. We supply research-grade Ipamorelin with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit. This compound is supplied strictly for laboratory research use only.

What makes Ipamorelin more selective than other GH secretagogues?

Earlier GH-releasing peptides such as GHRP-2 and GHRP-6 stimulate GH release but also trigger meaningful increases in cortisol, prolactin, and ACTH — hormones that can confound experimental results when studying the GH axis specifically. Ipamorelin was developed and has been validated in research for its ability to stimulate GH release through GHSR-1a with significantly less stimulation of these other hormones, making it a cleaner tool for studies that require isolated GH axis research without broader endocrine system interference.

What is the ghrelin receptor and why is it relevant to GH research?

The ghrelin receptor (GHSR-1a) is a G-protein coupled receptor expressed in the pituitary gland, hypothalamus, and throughout the gastrointestinal tract. In the pituitary, GHSR-1a activation stimulates growth hormone secretion — which is the primary mechanism through which Ipamorelin and other GH secretagogues work. The receptor’s presence in both the brain and gut also makes Ipamorelin relevant to research examining the intersection of GH regulation and gastrointestinal function.

How does Ipamorelin compare to CJC-1295 in research? Ipamorelin and CJC-1295 are frequently studied together because they stimulate GH release through different but complementary mechanisms — Ipamorelin through GHSR-1a (ghrelin receptor) and CJC-1295 through GHRHR (growth hormone releasing hormone receptor). Research combining both examines whether dual-pathway GH stimulation produces different or enhanced outcomes compared to either compound alone, making them a commonly paired research combination in GH axis studies.

What purity is required for Ipamorelin endocrinology research?

A minimum of ≥98% is considered research grade, though ≥99% is strongly preferred for sensitive GH secretion assays, receptor binding studies, and hormonal measurement experiments where compound purity directly affects result accuracy. All our Ipamorelin is independently verified to ≥99% purity.

How is Ipamorelin reconstituted for laboratory use?

Allow the vial to reach room temperature before opening. Add sterile or bacteriostatic water slowly down the vial wall and swirl gently without shaking. Aliquot immediately if longer-term storage at -80°C is required to preserve peptide integrity and avoid freeze-thaw degradation across multiple experimental uses.

How quickly is Ipamorelin delivered to UAE?

Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability throughout transit.

Research Disclaimer: Ipamorelin is supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic application. It must be handled by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. Handling should only be performed by qualified laboratory professionals in controlled research settings with appropriate institutional authorisations in place. By purchasing, you confirm that this compound will be used solely for approved in-vitro or pre-clinical research purposes.